Elsevier’s 2027 Intravenous Medications, 43rd Edition
COMING SOON – EXPECTED RELEASE JUNE 2026
Find the essential information you need to safely administer more than 400 intravenous drugs! The newest edition of a reference trusted for more than 50 years, Elsevier’s 2027 Intravenous Medications is a concise, quick-access guide to complete, accurate drug information. New to this edition are 10-20 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
New to this edition
| | NEW! Drug monographs for approximately 10-20 newly approved drugs by the FDA include the most current information |
| | NEW! Updates with new interactions, precautions, alerts, drug uses, patient teaching instructions, and more are included throughout the guide to reflect changes and prevent medication dispensing errors |
| | NEW! QR codes for additional drug monographs enable quick access at the point of care |
Key Features
| | Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference |
| | Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds |
| | Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more |
| | 50-year history of impeccable accuracy reinforces the importance of safe IV drug administration |
| | Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page |
| | Highlighted Black Box Warningsmake it easy to locate information on medications with serious safety risks |
| | Blue-screened text calls attention to other circumstances not covered by Black Box Warnings |
| | Dosage and dilution charts within monographs provide quick summaries of essential clinical information |
| | Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatalpatients |
| | Additional drug monographs are provided on the companion Evolve website |
Table of Contents:
General Dilution Charts
How to Use This Book
Evolve Website Information
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
IV Drugs
Alphabetical Drug Monographs
Appendix A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
Appendix B: FDA Pregnancy Categories
Appendix C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
Appendix D: Information for Patients Receiving Immunosuppressive Agents
Appendix E: Recently Approved Drugs
Index
PRODUCT DETAILS
| ISBN Number | 9780443433368 |
| Main Author | By Shelly Rainforth Collins, PharmD, BCGP |
| Copyright Year | 2027 |
| Edition Number | 43 |
| Format | Book |
| Trim | 152w x 229h (6.00" x 9.00") |
| Imprint | Elsevier |
| Page Count | 1344 |
| Publication Date | 18 Jun 2026 |